Bextra Microsite

We developed a microsite for Bextra (Valdecoxib), a nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis and rheumatoid arthritis. The content focused on the patient information of the new drug, which was launched in 2003. Two years later, Pfizer withdrew Bextra from the U.S. and European market.

Client Pfizer / Date #2003 / Category #Digital / Web Agency #Aseantic / Designer Marco Simonetti / Photographer Marco Simonetti / Consultant Pascal Schmid

Design Direction Marco Simonetti @Aseantic